Amyris

Amyris, Inc. engages in the provision of bioscience solutions. It offers its products to the health and wellness, clean beauty, and flavor and fragrance markets. The company was founded by Jack D. Newman, Kinkead Keith Reiling, and Neil Renninger on July 17, 2003 and is headquartered in Emeryville, CA.

Earnings data Q1 2024

The principal business of Tara Gold Resources Corp. is the acquisition, exploration and development of high-quality precious metals projects with potential for economic commercial value. Tara Gold is currently focused on acquiring and developing properties in the natural resource belt of the Sierra Madre Occidental and other prolific areas in the states of Chihuahua, Sonora, and Sinaloa, Mexico.  Tara Gold provides investors growth exposure with a diversified exploration portfolio, multiple multi-million ounce targets and several near term production scenarios. Tara Gold owns equity positions in Cayden Resources Inc. (TSX-V: CYD) and Tara Minerals Corp. (TARM.OB), a public US company which explores and develops high-quality precious & non-precious metals and mineral projects in Mexico.

Amyris has multiple major transactions around the corner. The political and market environment favor the company greatly.

Amyris Is Setting Up For A Monster Run

EMERYVILLE, Calif., Dec. 3, 2020 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands, and a top supplier of sustainable and natural ingredients, announced today that it will be...

Amyris Launches Virtual Investor Mini-Series

GrowGeneration Corp

These are the marijuana stocks with the best value, fastest growth, and most momentum for December.

Top Marijuana Stocks for December 2020

Aphria

Canopy Growth

Cronos Group

Village Farms International

These are the marijuana stocks on the NASDAQ with the best value, fastest growth, and the most momentum for November.

Top Marijuana Stocks on the NASDAQ for December 2020

Amyris, Inc. (AMRS) CEO John Melo on Q3 2020 Results - Earnings Call Transcript

EMERYVILLE, Calif., Oct. 30, 2020 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty markets through its consumer brands, and a top supplier of sustainable and natural ingredients, and Rosie Huntington-Whiteley, model turned...

Amyris And Rosie Huntington-Whiteley Announce Creation Of New Clean Beauty Brand And Business Partnership

BENSALEM, Pa.--(BUSINESS WIRE)---- $AMRS #CLASSACTION--INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Amyris, Inc. (AMRS) on Behalf of Investors

INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Amyris, Inc. (AMRS) on Behalf of Investors

LOS ANGELES--(BUSINESS WIRE)---- $AMRS #CLASSACTION--Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Amyris, Inc. (AMRS) on Behalf of Investors

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Amyris, Inc. (AMRS) on Behalf of Investors

EMERYVILLE, Calif., Oct. 23, 2020 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty markets through its consumer brands, and a top supplier of sustainable and natural ingredients, today announced that it will issue its...

Amyris To Host Third Quarter 2020 Financial Results Conference Call On November 5

SEATTLE, Oct. 20, 2020 /PRNewswire/ -- Arzeda, the Protein Design Company™, today announced that the company has entered into a joint development agreement with Amyris that leverages the complementary nature of the two companies' technology platforms to accelerate the development and...

Amyris and Arzeda Enter into Development Collaboration Agreement

LOS ANGELES--(BUSINESS WIRE)---- $AMRS #classaction--The Law Offices of Frank R. Cruz is investigating potential claims against the board of directors of Amyris, Inc (“Amyris” or the “Company”) (NASDAQ: AMRS) concerning whether the board breached its fiduciary duties to shareholders. If you are a shareholder, click here to participate. On March 19, 2019, Amyris announced was unable to file its annual report for fiscal year ended December 31, 2018 on time due to “the significant time and resources that were devoted to

The Law Offices of Frank R. Cruz Announces Investigation of Amyris, Inc. (AMRS) on Behalf of Investors

Why Amyris Fell 11% in September

Amyris' engineered yeast strains and advanced fermentation can produce an unlimited number of new products for billion-dollar markets.

R&D Surprises Offer Amyris Unbounded Upside

Amyris bolsters balance sheet, shifting focus to cash flow, 40-50% revenue growth and earnings (we estimate $0.72 EPS in 2024).

Amyris On Track For Cash Flow, Earnings And 70%/Year Returns

Amyris (NASDAQ: AMRS) shares were trading higher Tuesday after the company announced its Reb M Neutral Sweetener has received approval for use in food by Health Canada.

Why Amyris Shares Are Trading Higher Today

EMERYVILLE, Calif., Sept. 14, 2020 /PRNewswire/ -- Amyris, Inc.

Amyris to Provide Business Overview And Update On Current Affairs At H.C. Wainwright 22nd Annual Global Investment Conference Today

The company has responded to a $881 million lawsuit brought against it yesterday.

Why Amyris Shares Dropped 26% Today

Biotech firm Amyris Inc. (NASDAQ: AMRS) is clapping back at allegations made by Lavvan Inc.

Amyris Denies 'Patent Infringement' Allegations On Heels Of $881M Lavvan Lawsuit

EMERYVILLE, Calif., Sept. 11, 2020 /PRNewswire/ -- Amyris, Inc.

Amyris Responds To LAVVAN's Filing Of Lawsuit On September 10, 2020

NEW YORK, Sept. 10, 2020 /PRNewswire/ -- LAVVAN, Inc.

LAVVAN, Inc. Files $881 Million Federal Lawsuit Against Amyris, Inc.

Baudax Bio

aTyr Pharma

These penny stocks are company names that won’t break the bank, and boast colossal growth prospects for the 12 months ahead.
The post 3 Penny Stocks That Have Triple-Digit Upside Potential appeared first on InvestorPlace.

3 Penny Stocks That Have Triple-Digit Upside Potential

EMERYVILLE, Calif., Sept. 8, 2020 /PRNewswire/ -- Amyris, Inc.

Amyris to Present at H.C. Wainwright 22nd Annual Global Investment Conference on September 14, 2020

GW Pharmaceuticals

These are the marijuana stocks on the NASDAQ with the best value, fastest growth, and best performance for September.

Top Marijuana Stocks on the NASDAQ for September 2020

Unlocking the true value of the company's consumer portfolio might require a big, bold decision.

Should Amyris Split Into 2 Companies?

EMERYVILLE, Calif., Aug. 14, 2020 /PRNewswire/ -- Amyris, Inc.

News for Amyris Stock (AMRS)